Evidence of distinct populations of hepatitis C virus in the liver and plasma of patients co-infected with HIV and HCV

Journal of Medical Virology

Volumn 86, Issue 8, 2014, Pages 1332-1341

  Blackard, Jason T ^a   Ma, Gang ^a   Sengupta, Satarupa ^a   Martin, Christina M ^a   Powell, Eleanor A ^a   Shata, M Tarek ^a   Sherman, Kenneth E ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Co infection; Compartmentalization; Diversity; HCV; HIV; Quasispecies

Indexed keywords

AMINO ACID;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENTROPY; FEMALE; GENETIC DISTANCE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER; MALE; MIXED INFECTION; NUCLEOTIDE SEQUENCE; PHYLOGENY; PILOT STUDY; SEQUENCE ANALYSIS; UNINDEXED SEQUENCE; VIRUS REPLICATION; AGED; CLASSIFICATION; COMPLICATION; GENETIC VARIABILITY; GENETICS; HEPACIVIRUS; ISOLATION AND PURIFICATION; MIDDLE AGED; PLASMA; VIROLOGY;

ADULT; AGED; FEMALE; GENETIC VARIATION; HEPACIVIRUS; HEPATITIS C, CHRONIC; HIV INFECTIONS; HUMANS; LIVER; MALE; MIDDLE AGED; PLASMA;

EID: 84901775489     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23968     Document Type: Article

References (107)

1. Afonso A, Jian J, Penin F, Tareau C, Samuel D, Petit M, Bismuth H, Dussaix E, Feray C. 1999. Nonrandom distribution of hepatitis C virus quasispecies in plasma and peripheral blood mononuclear cell subsets. J Virol 73:9213-9221.
2. Alter M, Druszon-Moran D, Nainan O, McQuillan G, Gao F, Moyer L, Kaslow R, Margolis H. 1999. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 341:556-562.
3. Bare P. 2009. Hepatitis C virus and peripheral blood mononuclear cell reservoirs. World J Hepatol 1:67-71.
4. Bartolomé J, Rodríguez-Iñigo E, Quadros P, Vidal S, Pascual-Miguelañez I, Rodríguez-Montes JA, García-Sancho L, Carreño V. 2008. Detection of hepatitis C virus in thyroid tissue from patients with chronic HCV infection. J Med Virol 80:1588-1594.
5. Beld M, Penning M, Lukashov V, McMorrow M, Roos M, Pakker N, van den Hoek A, Goudsmit J. 1998. Evidence that both HIV and HIV-induced immunodeficiency enhance HCV replication among HCV seroconverters. Virology 244:504-512.
6. Bica I, McGovern B, Dhar R, Stone D, McGowan K, Scheib R, Snydman D. 2001. Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis 32:492-497.
7. Blackard J. 2012. HIV compartmentalization: A review on a clinically important phenomenon. Current HIV Res 10:133-142.
8. Blackard JT, Yang Y, Bordoni P, Sherman KE, Chung R, for the AIDS Clinical Trials Group 383 Study Team. 2004. Hepatitis C virus (HCV) diversity in HIV-HCV coinfected subjects initiating highly active antiretroviral therapy. J Infect Dis 189:1472-1481.
9. Blackard JT, Hiasa Y, Smeaton L, Jamieson DJ, Rodriguez I, Mayer KH, Chung R. 2007. Compartmentalization of hepatitis C virus (HCV) during HCV/HIV coinfection. J Infect Dis 195:1765-1773.
10. Blackard JT, Ma G, Limketkai BN, Welge JA, Dryer PD, Martin CM, Hiasa Y, Taylor LE, Mayer KH, Jamieson DJ, Sherman K. 2010. Variability of the polymerase gene (NS5B) in hepatitis C virus-infected women. J Clin Microbiol 48:4256-4259.
11. Blackard JT, Ma G, Welge JA, Martin CM, Sherman KE, Taylor LE, Mayer KH, Jamieson D. 2012. Analysis of a non-structural gene reveals evidence of possible hepatitis C virus (HCV) compartmentalization. J Med Virol 84:242-252.
12. Bozdayi AM, Uzunalimoglu O, Aslan N, Bozkaya H, Türkyilmaz AR, Kayhan B, Sahin T, Sivri B, Uygun A, Altiok A, Cetinkaya H, Karayalçin S, Yurdaydin C. 2000. Influence of viral load and alanine aminotransferase on viral genetic heterogeneity in patients with chronic hepatitis C virus infection. Intervirology 43:61-66.
13. Brambilla S, Bellati G, Asti M, Lisa A, Candusso M, D'Amico M, Grassi G, Giacca M, Franchini A, Bruno S, Ideo G, Mondelli M, Silini E. 1998. Dynamics of hypervariable region 1 variation in hepatitis C virus infection and correlation with clinical and virological features of liver disease. Hepatology 27:1678-1686.
14. Caussin-Schwemling C, Schmitt C, Stoll-Keller F. 2001. Study of the infection of human blood derived monocyte/macrophages with hepatitis C virus in vitro. J Med Virol 65:14-22.
15. Chen S, Wang Y. 2005. Multigene tracking of quasispecies in viral persistence and clearance of hepatitis C virus. World J Gastroenterol 11:2874-2884.
16. Chung R, Evans S, Yang Y, Theodore D, Valdez H, Clark R, Shikuma C, Nevin T, Sherman K, for the AIDS Clinical Trials Group 383 Study Team. 2002. Immune recovery is associated with persistent rise in hepatitis C RNA, infrequent liver test flares, and is not impaired by hepatitis C in co-infected subjects. AIDS 16:1915-1923.
17. Chung RT, Andersen J, Volberding P, Robbins GK, Liu T, Sherman KE, Peters MG, Koziel MJ, Bhan AK, Alston B, Colquhoun D, Nevin T, Harb G, van der Horst C, for the AIDS Clinical Trials Group A5071 Study Team. 2004. Peginterferon alpha-2a plus ribavirin versus interferon alpha-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons. N Engl J Med 351:451-459.
18. Cooper C, Cameron D. 2002. Review of the effect of highly active antiretroviral therapy on hepatitis C virus (HCV) RNA levels in human immunodeficiency virus and HCV coinfection. Clin Infect Dis 35:873-879.
19. Curran R, Jameson C, Craggs J, Grabowska A, Thomson B, Robins A, Irving W, Ball J. 2002. Evolutionary trends of the first hypervariable region of the hepatitis C virus E2 protein in individuals with differing liver disease severity. J Gen Virol 83:11-23.
20. Di Liberto G, Roque-Afonso AM, Kara R, Ducoulombier D, Fallot G, Samuel D, Feray C. 2006. Clinical and therapeutic implications of hepatitis C virus compartmentalization. Gastroenterology 131:76-84.
21. DiMartino V, Rufat P, Boyer N, Renard P, Degos F, Martinot-Peignoux M, Matheron S, Le Moing V, Vachon F, Degott C, Valla D, Marcellin P. 2001. The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: A long-term retrospective cohort study. Hepatology 34:1193-1199.
22. Drummond AJ, Suchard MA, Xie D, Rambaut A. 2012. Bayesian phylogenetics with BEAUti and the BEAST 1.7. Mol Biol Evol 29:1969-1973.
23. Ducoulombier D, Roque-Afonso AM, Di Liberto G, Penin F, Kara R, Richard Y, Dussaix E, Feray C. 2004. Frequent compartmentalization of hepatitis C virus variants in circulating B cells and monocytes. Hepatology 39:817-825.
24. Farci P. 2011. New insights into the HCV quasispecies and compartmentalization. Semin Liver Dis 31:356-374.
25. Farci P, Shimoda A, Coiana A, Diaz G, Peddis G, Melpolder J, Strazzera A, Chien D, Munoz S, Balestrieri A, Purcell R, Alter H. 2000. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science 288:339-344.
26. Farci P, Quinti I, Farci S, Alter HJ, Strazzera R, Palomba E, Coiana A, Cao D, Casadei AM, Ledda R, Iorio R, Vegnente A, Diaz G, Tovo P. 2006. Evolution of hepatitis C viral quasispecies and hepatic injury in perinatally infected children followed prospectively. Proc Natl Acad Sci U S A 103:8475-8848.
27. Felsenstein J. 1985. Confidence limits on phylogenies: An approach using the bootstrap. Evolution 39:783-791.
28. Forton DM, Karayiannis P, Mahmud N, Taylor-Robinson SD, Thomas H. 2004. Identification of unique hepatitis C virus quasispecies in the central nervous system and comparative analysis of internal translational efficiency of brain, liver, and serum variants. J Virol 78:5170-5183.
29. Gong G, Lai L, Jiang Y, He Y, Su X. 2003. HCV replication in PBMC and its influence on interferon therapy. World J Gastroenterol 9:291-294.
30. Goutagny N, Fatmi A, De Ledinghen V, Penin F, Couzigou P, Ichauspe G, Bain C. 2003. Evidence of viral replication in circulating dendritic cells during hepatitis C virus infection. J Infect Dis 187:1951-1958.
31. Gretch D, Polyak S, Wilson J, Carithers R, Perkins J, Corey L. 1996. Tracking hepatitis C virus quasispecies major and minor variants in symptomatic and asymptomatic liver transplant recipients. J Virol 70:7622-7631.
32. Hamano K, Sakamoto N, Enomoto N, Izumi N, Asahina Y, Kurosaki M, Ueda E, Tanabe Y, Maekawa S, Itakura J, Watanabe H, Kakinuma S, Watanabe M. 2005. Mutations in the NS5B region of the hepatitis C virus genome correlate with clinical outcomes of interferon-alpha plus ribavirin combination therapy. J Gastroenterol Hepatol 20:1401-1409.
33. Hanada K, Tanaka Y, Mizokami M, Gojobori T, Alter H. 2007. A reduction in selective immune pressure during the course of chronic hepatitis C correlates with diminished biochemical evidence of hepatic inflammation. Virology 361:27-33.
34. Hayashi J, Furusyo N, Ariyama I, Sawayama Y, Etoh Y, Kashiwagi S. 2000. A relationship between the evolution of hepatitis C virus variants, liver damage, and hepatocellular carcinoma in patients with hepatitis C viremia. J Infect Dis 181:1523-1527.
35. Itakura J, Nagayama K, Enomoto N, Hamano K, Sakamoto N, Fanning LJ, Kenny-Walsh E, Shanahan F, Watanabe M. 2005. Viral load change and sequential evolution of entire hepatitis C virus genome in Irish recipients of single source-contaminated anti-D immunoglobulin. J Viral Hepat 12:594-603.
36. Jang SJ, Wang LJ, Radkowski M, Rakela J, Laskus T. 1999. Differences between hepatitis C virus 5' untranslated region quasispecies in serum and liver. J Gen Virol 80:711-716.
37. John M, Flexman J, French M. 1998. Hepatitis C virus-associated hepatitis following treatment of HIV-infected patients with HIV protease inhibitors: An immune response restoration disease? AIDS 12:2289-2293.
38. Korber B, Myers G. 1992. Signature pattern analysis: A method for assessing viral sequence relatedness. AIDS Res Hum Retroviruses 8:1549-1560.
39. Kumar S, Dudley J, Nei M, Tamura K. 2008. MEGA: A biologist-centric software for evolutionary analysis of DNA and protein sequences. Brief Bioinform 9:299-306.
40. Laporte J, Malet I, Andrieu T, Thibault V, Toulme J, Wychowski C, Pawlotsky J, Huraux J, Agut H, Cahour A. 2000. Comparative analysis of translation efficiencies of hepatitis C virus 5' untranslated regions among intraindividual quasispecies present in chronic infection: Opposite behaviors depending on cell type. J Virol 74:10827-10833.
41. Laporte J, Bain C, Maurel P, Inchauspe G, Agut H, Cahour A. 2003. Differential distribution and internal translation efficiency of hepatitis C virus quasispecies present in dendritic and liver cells. Blood 101:52-57.
42. Laskus T, Radkowski M, Wang L, Cianciara J, Vargas H, Rakela J. 1997. Hepatitis C virus negative strand RNA is not detected in peripheral blood mononuclear cells and viral sequences are identical to those in serum: A case against extrahepatic replication. J Gen Virol 78:2747-2750.
43. Laskus T, Radkowski M, Wang L, Jang S, Vargas H, Rakela J. 1998a. Hepatitis C virus quasispecies in patients infected with HIV-1: Correlation with extrahepatic replication. Virology 248:164-171.
44. Laskus T, Radkowski M, Wang L, Vargas H, Rakela J. 1998b. Search for hepatitis C virus extrahepatic replication sites in patients with acquired immunodeficiency syndrome: Specific detection of negative-strand viral RNA in various tissues. Hepatology 28:1398-1401.
45. Laskus T, Radkowski M, Wang L, Nowicki M, Rakela J. 2000. Uneven distribution of hepatitis C virus quasispecies in tissues from subjects with end-stage liver disease: Confounding effect of viral adsorption and mounting evidence for the presence of low-level extrahepatic replication. J Virol 74:1014-1017.
46. Layden-Almer JE, Kuiken C, Ribeiro RM, Kunstman KJ, Perelson AS, Layden TJ, Wolinsky SM. 2005. Hepatitis C virus genotype 1a NS5A pretreatment sequence variation and viral kinetics in African American and white patients. J Infect Dis 192:1078-1087.
47. Le Pogam S, Seshaadri A, Kosaka A, Chiu S, Kang H, Hu S, Rajyaguru S, Symons J, Cammack N, Nájera I. 2008. Existence of hepatitis C virus NS5B variants naturally resistant to non-nucleoside, but not to nucleoside, polymerase inhibitors among untreated patients. J Antimicrob Chemother 61:1205-1216.
48. Lerat H, Rumin S, Habersetzer F, Berby F, Trabaud M, Trepo C, Inchauspe G. 1998. In vivo tropism of hepatitis C virus genomic sequences in hematopoietic cells: Influence of viral load, viral genotype, and cell phenotype. Blood 91:3841-3849.
49. Lerat H, Shimizu Y, Lemon S. 2000. Cell type-specific enhancement of hepatitis C virus internal ribosome entry site-directed translation due to 5' nontranslated region substitutions selected during passage of virus in lymphoblastoid cells. J Virol 74:7024-7031.
50. Lesens O, Deschenes M, Steben M, Belanger G, Tsoukas G. 1999. Hepatitis C virus is related to progressive liver disease in human immunodeficiency virus-positive hemophiliacs and should be treated as an opportunistic infection. J Infect Dis 179:1254-1258.
51. Lévêque VJ, Wang Q. 2002. RNA-dependent RNA polymerase encoded by hepatitis C virus: Biomedical applications. Cell Mol Life Sci 59:909-919.
52. Li H, Atkins E, Bruckner J, McArdle S, Qiu WC, Thomassen LV, Scott J, Shuhart MC, Livingston S, Townshend-Bulson L, McMahon BJ, Harris M, Griffin S, Gretch D. 2012. Genetic and functional heterogeneity of the hepatitis C virus p7 ion channel during natural chronic infection. Virology 423:30-37.
53. Liu L, Fisher BE, Thomas DL, Cox AL, Ray S. 2012. Spontaneous clearance of primary acute hepatitis C virus infection correlated with high initial viral RNA level and rapid HVR1 evolution. Hepatology 55:1684-1691.
54. Lohmann V, Roos A, Körner F, Koch JO, Bartenschlager B. 2000. Biochemical and structural analysis of the NS5B RNA-dependent RNA polymerase of the hepatitis C virus. J Viral Hepat 7:167-174.
55. Maggi F, Fornai C, Vatteroni ML, Giorgi M, Morrica A, Pistello M, Cammarota G, Marchi S, Ciccorossi P, Bionda A, Bendinelli M. 1997. Differences in hepatitis C virus quasispecies composition between liver, peripheral blood mononuclear cells and plasma. J Gen Virol 78:1521-1525.
56. Maggi F, Fornai C, Morrica A, Vatteroni M, Giorgi M, Marchi S, Ciccorossi P, Bendinelli M, Pistello M. 1999. Divergent evolution of hepatitis C virus in liver and peripheral blood mononuclear cells of infected patients. J Med Virol 57:57-63.
57. Manzin A, Solforosi L, Petrelli E, Macarri G, Tosone G, Piazza M, Clementi M. 1998. Evolution of hypervariable region 1 of hepatitis C virus in primary infection. J Virol 72:6271-6276.
58. Mao Q, Ray SC, Laeyendecker O, Ticehurst JR, Strathdee SA, Vlahov D, Thomas D. 2001. Human immunodeficiency virus seroconversion and evolution of the hepatitis C virus quasispecies. J Virol 75:3259-3267.
59. Martell M, Esteban J, Quer J, Vargas V, Esteban R, Guardia J, Gomez J. 1994. Dynamic behavior of hepatitis C virus quasispecies in patients undergoing orthotopic liver transplantation. J Virol 68:3425-3436.
60. Martinez-Sierra C, Arizcorreta A, Diaz F, Roldan R, Martin-Herrera L, Perez-Guzman E, Giron-Gonzalez J. 2003. Progression of chronic hepatitis C to liver fibrosis and cirrhosis in patients coinfected with hepatitis C virus and human immunodeficiency virus. Clin Infect Dis 36:491-498.
61. Mazur W, Mazurek U, Jurzak M, Wilczok T, Bulanowski Z, Gonciarz Z. 2001. Positive and negative strands of HCV-RNA in sera and peripheral blood mononuclear cells of chronically hemodialyzed patients. Med Sci Monit 7:108-115.
62. Mohsen A, Easterbrook P, Taylor C, Portmann B, Kulasegaram R, Murad S, Wiselka M, Norris S. 2003. Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients. Gut 52:1035-1040.
63. Nagayama K, Kurosaki M, Enomoto N, Maekawa SY, Miyasaka Y, Tazawa J, Izumi N, Marumo F, Sato C. 1999. Time-related changes in full-length hepatitis C virus sequences and hepatitis activity. Virology 263:244-253.
64. Navas S, Martin J, Quiroga JA, Castillo I, Carreno V. 1998. Genetic diversity and tissue compartmentalization of the hepatitis C virus genome in blood mononuclear cells, liver, and serum from chronic hepatitis C patients. J Virol 72:1640-1646.
65. Nickle DC, Shriner D, Mittler JE, Frenkel LM, Mullins J. 2003. Importance and detection of virus reservoirs and compartments of HIV infection. Curr Opin Microbiol 6:410-416.
66. Okuda M, Hino K, Korenaga M, Yamaguchi Y, Katoh Y, Okita K. 1999. Differences in hypervariable region 1 quasispecies of hepatitis C virus in human serum, peripheral blood mononuclear cells, and liver. Hepatology 29:217-222.
67. Pawlotsky J. 2000. Hepatitis C virus resistance to antiviral therapy. Hepatology 32:889-896.
68. Pellerin M, Lopez-Aguirre Y, Penin F, Dhumeaux D, Pawlotsky J. 2004. Hepatitis C virus quasispecies variability modulates nonstructural protein 5A transcriptional activation, pointing to cellular compartmentalization of virus-host interactions. J Virol 78:4617-4627.
69. Perez-Olmeda M, Nunez M, Romero M, Gonzalez J, Castro A, Arribas JR, Pedreira J, Barreiro P, Garcia-Samaniego J, Martin-Carbonero L, Jimenez-Nacher I, Soriano V. 2003. Pegylated IFN-alpha2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients. AIDS 17:1023-1028.
70. Pett S, Dore G, Fielden R, Cooper D. 2002. Cyclical hepatitis and early liver cirrhosis after hepatitis C seroconversion during pulsed antiretroviral therapy for primary HIV-1. AIDS 16:2364-2365.
71. Pond SL, Frost SD, Muse S. 2005. HyPhy: Hypothesis testing using phylogenetics. Bioinformatics 21:676-679.
72. Poynard T, Mathurin P, Lai C, Guyader D, Poupon R, Tainturier M, Myers R, Muntenau M, Ratziu V, Manns M, Vogel A, Capron F, Chedid A, Bedossa P. 2003. A comparison of fibrosis progression in chronic liver diseases. J Hepatol 38:257-265.
73. Puoti M, Bonancini M, Spinetti A, Putzolu V, Govindarajan S, Zaltron S, Favret M, Callea F, Gargiulo F, Donato F, Carosi G, for the HIV-HCV Coinfection Study Group. 2001. Liver fibrosis progression is related to CD4 cell depletion in patients coinfected with hepatitis C virus and human immunodeficiency virus. J Infect Dis 183:134-137.
74. Radkowski M, Wilkinson J, Nowicki M, Adair D, Vargas H, Ingui C, Rakela J, Laskus T. 2002. Search for hepatitis C virus negative-strand RNA sequences and analysis of viral sequences in the central nervous system: Evidence of replication. J Virol 76:600-608.
75. Radkowski M, Bednarska A, Horban A, Stanczak J, Wilkinson J, Adair DM, Nowicki M, Rakela J, Laskus T. 2004. Infection of primary human macrophages with hepatitis C virus in vitro: Induction of tumour necrosis factor-a and interleukin 8. J Gen Virol 85:47-59.
76. Ragni M, Belle S. 2001. Impact of human immunodeficiency virus infection on progress to end-stage liver disease in individuals with hemophilia and hepatitis C virus infection. J Infect Dis 183:1112-1115.
77. Ragni M, Bontempo F. 1999. Increase in hepatitis C viral load in hemophiliacs during treatment with highly active antiretroviral therapy. J Infect Dis 180:2027-2029.
78. Ramirez S, Perez-Del-Pulgar S, Carrion JA, Costa J, Gonzalez P, Massaguer A, Fondevila C, Garcia-Valdecasas JC, Navasa M, Forns X. 2009. Hepatitis C virus compartmentalization and infection recurrence after liver transplantation. Am J Transplant 9:1591-1601.
79. Ray S, Wang Y, Laeyendecker O, Ticehurst J, Villano S, Thomas D. 1999. Acute hepatitis C virus structural gene sequences as predictors of persistent viremia: Hypervariable region 1 as a decoy. J Virol 73:2938-2946.
80. Roque-Afonso A, Jiang J, Penin F, Tareau C, Samuel D, Petit M, Bismuth H, Dussaix E, Feray C. 1999. Nonrandom distribution of hepatitis C virus quasispecies in plasma and peripheral blood mononuclear cell subsets. J Virol 73:9213-9221.
81. Roque-Afonso A, Ducoulombier D, Di Liberto G, Kara R, Gigou M, Dussaix E, Samuel D, Feray C. 2005. Compartmentalization of hepatitis C virus genotypes between plasma and peripheral blood mononuclear cells. J Virol 79:6349-6357.
82. Rosenberg MS, Anderson C. 2011. PASSaGE: Pattern analysis, spatial statistics and geographic exegesis. Version 2. Methods Ecol Evol 2:229-232.
83. Rutschmann O, Negro F, Hirschel B, Hadengue A, Anwar D, Perrin L. 1998. Impact of treatment with human immunodeficiency virus (HIV) protease inhibitors on hepatitis C viremia in patients coinfected with HIV. J Infect Dis 177:783-785.
84. Saleh M, Tibbs C, Koskinas J, Pereira L, Bomford A, Portmann B, McFarlane I, Williams R. 1994. Hepatic and extrahepatic hepatitis C virus replication in relation to response to interferon therapy. Hepatology 20:1399-1404.
85. Salmon-Ceron D, Lewden C, Morlat P, Bévilacqua S, Jougla E, Bonnet F, Héripret L, Costagliola D, May T, Chêne G, for the Mortality Group 2000. 2005. Liver disease as a major cause of death among HIV infected patients: Role of hepatitis C and B viruses and alcohol. J Hepatol 42:799-805.
86. Schramm F, Soulier E, Royer C, Weitten T, Fafi-Kremer S, Brignon N, Meyer N, Ellero B, Woehl-Jaegle ML, Meyer C, Wolf P, Doffoël M, Baumert TF, Stoll-Keller F, Schvoerer E. 2008. Frequent compartmentalization of hepatitis C virus with leukocyte-related amino acids in the setting of liver transplantation. J Infect Dis 198:1656-1666.
87. Sherman KE, Andreatta C, O'Brien J, Gutierrez A, Harris R. 1996. Hepatitis C in human immunodeficiency virus-coinfected patients: Increased variability in the hypervariable envelope coding domain. Hepatology 23:688-694.
88. Sherman K, Rouster S, Chung R, Rajicic N. 2002. Hepatitis C virus prevalence among patients infected with human immunodeficiency virus: A cross-sectional analysis of the US Adult AIDS Clinical Trials Groups. Clin Infect Dis 34:831-837.
89. Sherman KE, Rouster SD, Stanford S, Blackard JT, Shire N, Koziel M, Peters M, Chung RT, for the AIDS Clinical Trials Group 5071 Study Team. 2010. Hepatitis C virus (HCV) quasispecies complexity and selection in HCV/HIV coinfected subjects treated with interferon-based regimens. J Infect Dis 201:712-719.
90. Shimizu Y, Igarashi H, Kanematu T, Fujiwara K, Wong D, Purcell R, Yoshikura H. 1997. Sequence analysis of the hepatitis C virus genome recovered from serum, liver, and peripheral blood mononuclear cells of infected chimpanzees. J Virol 71:5769-5773.
91. Shuhart MC, Sullivan DG, Bekele K, Harrington RD, Kitahata MM, Mathisen TL, Thomassen LV, Emerson SS, Gretch D. 2006. HIV infection and antiretroviral therapy: Effect on hepatitis C virus quasispecies variability. J Infect Dis 193:1211-1218.
92. Slatkin M, Maddison W. 1989. A cladistic measure of gene flow inferred from the phylogenies of alleles. Genetics 123:603-613.
93. Sobesky R, Feray C, Rimlinger F, Derian N, Dos Santos A, Roque-Afonso AM, Samuel D, Bréchot C, Thiers V. 2007. Distinct hepatitis C virus core and F protein quasispecies in tumoral and nontumoral hepatocytes isolated via microdissection. Hepatology 46:1704-1712.
94. Soto B, Sanchez-Quijano A, Rodrigo L, del Olmo J, Garcia-Bengoechea M, Hernandez-Quero J, Rey C, Abad M, Rodriquez M, Gilabert M, Gonzalez F, Miron P, Caruz A, Relimpio F, Torronteras F, Leal M, Lissen E. 1997. Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis. J Hepatol 26:1-5.
95. Sullivan D, Wilson J, Carithers R, Perkins J, Gretch D. 1998. Multigene tracking of hepatitis C virus quasispecies after liver transplantation: Correlation of genetic diversification in the envelope region with asymptomatic or mild disease patterns. J Virol 72:10036-10043.
96. Taliani G, Badolato M, Lecce R, Poliandri G, Bozza A, Duca F, Pasquazzi C, Clementi C, Furlan C, Bac CD. 1995. Hepatitis C virus RNA in peripheral blood mononuclear cells: Relation with response to interferon treatment. J Med Virol 47:16-22.
97. Tanaka Y, Hanada K, Hanabusa H, Kurbanov F, Gojobori T, Mizokami M. 2007. Increasing genetic diversity of hepatitis C virus in haemophiliacs with human immunodeficiency virus coinfection. J Gen Virol 88:2513-2519.
98. Tedaldi EM, Baker RK, Moorman AC, Alzola CF, Furhrer J, McCabe RE, Wood KC, Holmberg SD, for the HIV Outpatient Study (HOPS) Investigators. 2003. Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy. Clin Infect Dis 36:363-367.
99. Thompson J, Gibson T, Plewniak F, Jeanmougin F, Higgins D. 1997. The CLUSTAL X windows interface: Flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 25:4876-4882.
100. Torres-Puente M, Bracho M, Jiminez N, Garcia-Robles I, Moya A, Gonzalez-Candelas F. 2003. Sampling and repeatability in the evaluation of hepatitis C virus genetic variability. J Gen Virol 84:2343-2350.
101. Toyoda H, Fukuda Y, Koyama Y, Takamatsu J, Saito H, Hayakawa T. 1997. Effect of immunosuppression on composition of quasispecies population of hepatitis C virus in patients with chronic hepatitis C coinfected with human immunodeficiency virus. J Hepatol 26:975-982.
102. Vera-Otarola J, Barría MI, León U, Marsac D, Carvallo P, Soza A, López-Lastra M. 2009. Hepatitis C virus quasispecies in plasma and peripheral blood mononuclear cells of treatment naïve chronically infected patients. J Viral Hepat 16:633-643.
103. Weiner A, Geysen H, Christopherson C, Hall J, Mason T, Saracco G, Bonino F, Crawford K, Marion C, Crawford K, Brunetto M, Barr P, Miyamura T, McHutchinson J, Houghton M. 1992. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: Potential role in chronic HCV infections. Proc Natl Acad Sci U S A 89:3468-3472.
104. Yee T, Griffioen A, Sabin C, Dusheiko G, Lee C. 2000. The natural history of HCV in a cohort of haemophilic patients infected between 1961 and 1985. Gut 47:845-851.
105. Yokozaki S, Takamatsu J, Nakano I, Katano Y, Toyoda H, Hayashi K, Hayakawa T, Fukuda Y. 2000. Immunological dynamics in hemophiliac patients infected with hepatitis C virus and human immunodeficiency virus: Influence of antiretroviral therapy. Blood 96:4293-4299.
106. Zárate S, Pond SL, Shapshak P, Frost S. 2007. Comparative study of methods for detecting sequence compartmentalization in human immunodeficiency virus type 1. J Virol 81:6643-6651.
107. Zehender G, De Maddalena C, Bernini F, Ebranati E, Monti G, Pioltelli P, Galli M. 2005. Compartmentalization of hepatitis C virus quasispecies in blood mononuclear cells of patients with mixed cryoglobulinemic syndrome. J Virol 79:9145-9156.